The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Mechanism of Action of an EPAC1-Selective Competitive Partial Agonist
Abstract
The exchange protein activated by cAMP (EPAC) is a promising drug target for a wide disease range, from neurodegeneration and infections to cancer and cardiovascular conditions. A novel partial agonist of the EPAC isoform 1 (EPAC1), I942, was recently discovered, but its mechanism of action remains poorly understood. Here, we utilize NMR spectroscopy to map the I942–EPAC1 interactions at atomic resolution and propose a mechanism for I942 partial agonism. We found that I942 interacts with the phosphate binding cassette (PBC) and base binding region (BBR) of EPAC1, similar to cyclic adenosine monophosphate (cAMP). These results not only reveal the molecular basis for the I942 vs cAMP mimicry and competition, but also suggest that the partial agonism of I942 arises from its ability to stabilize an inhibition-incompetent activation intermediate distinct from both active and inactive EPAC1 states. The mechanism of action of I942 may facilitate drug design for EPAC-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The growing cohort of CHESPA and CHESCA applications (Akimoto et al., 2013;Axe et al., 2014;Chen et al., 2017;Selvaratnam et al., 2011Selvaratnam et al., , 2012;;Shao et al., 2020;VanSchouwen et al., 2015;Walker et al., 2019;Wang et al., 2019;Xu et al., 2019) illustrates the potential of these methods.”
From CHESPA/CHESCA-SPARKY: automated NMR data analysis plugins for SPARKY to map protein allostery (2021) · cites this paper as Shao et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multifunctional Mitochondrial Epac1 Controls Myocardial Cell Death
Fazal, L., Laudette, M., Paula-Gomes, S., Pons, S., Conte, C., Tortosa, F., Sicard, P., Sainte-Marie, Y., Bisserier, M., Lairez, O., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.309859 · Cited by 111
Research works printed but not linked: 80
- Kawasaki, 1998, A family of cAMP-binding proteins that directly activate Rap1, Science, 282, 2275, 10.1126/science.282.5397.2275 · DOI · Paper page
- de Rooij, 1998, Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP, Nature, 396, 474, 10.1038/24884 · DOI · Paper page
- de Rooij, 2000, Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs, J. Biol. Chem., 275, 20829, 10.1074/jbc.M001113200 · DOI · Paper page
- Schmidt, 2013, Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions, Pharmacol. Rev., 65, 670, 10.1124/pr.110.003707 · DOI · Paper page
- Robichaux, 2018, Intracellular cAMP sensor EPAC: physiology, pathophysiology, and therapeutics development, Physiol. Rev., 98, 919, 10.1152/physrev.00025.2017 · DOI · Paper page
- Kaneko, 2004, Presynaptic mechanism underlying cAMP-dependent synaptic potentiation, J. Neurosci., 24, 5202, 10.1523/JNEUROSCI.0999-04.2004 · DOI · Paper page
- Yang, 2012, EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation, Neuron, 73, 774, 10.1016/j.neuron.2012.02.003 · DOI · Paper page
- Morel, 2005, cAMP-binding protein Epac induces cardiomyocyte hypertrophy, Circ. Res., 97, 1296, 10.1161/01.RES.0000194325.31359.86 · DOI · Paper page
- Métrich, 2008, Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy, Circ. Res., 102, 959, 10.1161/CIRCRESAHA.107.164947 · DOI · Paper page
- Laurent, 2015, Exchange protein directly activated by cAMP 1 promotes autophagy during cardiomyocyte hypertrophy, Cardiovasc. Res., 105, 55, 10.1093/cvr/cvu242 · DOI
- Rangarajan, 2003, Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor, J. Cell Biol., 160, 487, 10.1083/jcb.200209105 · DOI · Paper page
- Bastian, 2009, The inhibitory effect of norepinephrine on the migration of ES-2 ovarian carcinoma cells involves a Rap1-dependent pathway, Cancer Lett., 274, 218, 10.1016/j.canlet.2008.09.008 · doi:10.1016/j.canlet.2008.09.008
- Yan, 2013, Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1, Mol. Cell. Biol., 33, 918, 10.1128/MCB.01227-12 · DOI
- Almahariq, 2015, Pharmacological inhibition and genetic knockdown of exchange protein directly activated by cAMP 1 reduce pancreatic cancer metastasis in vivo, Mol. Pharmacol., 87, 142, 10.1124/mol.114.095158 · doi:10.1124/mol.114.095158
- Hu, 2016, Role of exchange protein directly activated by cyclic AMP isoform 1 in energy homeostasis: regulation of leptin expression and secretion in white adipose tissue, Mol. Cell. Biol., 36, 2440, 10.1128/MCB.01034-15 · DOI
- Gao, 2016, Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo, Med. Oncol., 33, 10.1007/s12032-016-0786-0 · DOI
- Kumar, 2017, Role of exchange protein directly activated by cAMP (EPAC1) in breast cancer cell migration and apoptosis, Mol. Cell. Biochem., 430, 115, 10.1007/s11010-017-2959-3 · doi:10.1007/s11010-017-2959-3
- Hwang, 2017, Epac2a-null mice exhibit obesity-prone nature more susceptible to leptin resistance, Int. J. Obes., 41, 279, 10.1038/ijo.2016.208 · DOI
- Almahariq, 2013, A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion, Mol. Pharmacol., 83, 122, 10.1124/mol.112.080689 · DOI · Paper page
- Wang, 2017, Lithium and an EPAC-specific inhibitor ESI-09 synergistically suppress pancreatic cancer cell proliferation and survival, Acta Biochim. Biophys. Sin., 49, 573, 10.1093/abbs/gmx045 · DOI
- Gong, 2013, Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses, Proc. Natl. Acad. Sci. U.S.A., 110, 19615, 10.1073/pnas.1314400110 · DOI
- Tao, 2014, Blocking of exchange proteins directly activated by cAMP leads to reduced replication of Middle East respiratory syndrome coronavirus, J. Virol., 88, 3902, 10.1128/JVI.03001-13 · DOI
- Dawn, 2014, The central role of cAMP in regulating Plasmodium falciparum merozoite invasion of human erythrocytes, PLoS Pathog., 10, 10.1371/journal.ppat.1004520 · DOI
- McPhee, 2005, Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer’s disease, Biochem. Soc. Trans., 33, 1330, 10.1042/BST0331330 · doi:10.1042/bst0331330
- Singhmar, 2016, Critical role for Epac1 in inflammatory pain controlled by GRK2-mediated phosphorylation of Epac1, Proc. Natl. Acad. Sci. U.S.A., 113, 3036, 10.1073/pnas.1516036113 · DOI
- Wang, 2013, Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain, J. Clin. Invest., 123, 5023, 10.1172/JCI66241 · DOI
- Wan, 2014, Activation of exchange protein activated by cAMP in the rat basolateral amygdala impairs reconsolidation of a memory associated with self-administered cocaine, PLoS ONE, 9, 10.1371/journal.pone.0107359 · DOI
- Bos, 2006, Epac proteins: multi-purpose cAMP targets, Trends Biochem. Sci., 31, 680, 10.1016/j.tibs.2006.10.002 · DOI · Paper page
- Rehmann, 2006, Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state, Nature, 439, 625, 10.1038/nature04468 · DOI · Paper page
- Mazhab-Jafari, 2007, Understanding cAMP-dependent allostery by NMR spectroscopy: comparative analysis of the EPAC1 cAMP-binding domain in its apo and cAMP-bound states, J. Am. Chem. Soc., 129, 14482, 10.1021/ja0753703 · DOI
- VanSchouwen, 2011, Role of dynamics in the autoinhibition and activation of the exchange protein directly activated by cyclic AMP (EPAC), J. Biol. Chem., 286, 42655, 10.1074/jbc.M111.277723 · DOI
- Das, 2008, Entropy-driven cAMP-dependent allosteric control of inhibitory interactions in exchange proteins directly activated by cAMP, J. Biol. Chem., 283, 19691, 10.1074/jbc.M802164200 · DOI
- Rehmann, 2008, Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B, Nature, 455, 124, 10.1038/nature07187 · DOI · Paper page
- Rehmann, 2003, Structure and regulation of the cAMP-binding domains of Epac2, Nat. Struct. Biol., 10, 26, 10.1038/nsb878 · DOI · Paper page
- Kraemer, 2001, Dynamic interaction of cAMP with the Rap guanine-nucleotide exchange factor Epac1, J. Mol. Biol., 306, 1167, 10.1006/jmbi.2001.4444 · DOI
- Kukic, 2015, Structure and dynamics of the integrin LFA-1 I-domain in the inactive state underlie its inside-out/outside-in signaling and allosteric mechanisms, Structure, 23, 745, 10.1016/j.str.2014.12.020 · DOI
- Gagné, 2015, Network of long-range concerted chemical shift displacements upon ligand binding to human angiogenin, Protein Sci., 24, 525, 10.1002/pro.2613 · DOI
- Cembran, 2014, NMR mapping of protein conformational landscapes using coordinated behavior of chemical shifts upon ligand binding, Phys. Chem. Chem. Phys., 16, 6508, 10.1039/C4CP00110A · DOI · Paper page
- De, 2012, Complete thermodynamic and kinetic characterization of the isomer-specific interaction between Pin1-WW domain and the amyloid precursor protein cytoplasmic tail phosphorylated at Thr668, Biochemistry, 51, 8583, 10.1021/bi3008214 · DOI
- Boehr, 2009, The role of dynamic conformational ensembles in biomolecular recognition, Nat. Chem. Biol., 5, 789, 10.1038/nchembio.232 · DOI · Paper page
- de Simone, 2015, Structure of a low-population intermediate state in the release of an enzyme product, eLife, 4, 10.7554/eLife.02777 · DOI
- Selvaratnam, 2012, The projection analysis of NMR chemical shifts reveals extended EPAC autoinhibition determinants, Biophys. J., 102, 630, 10.1016/j.bpj.2011.12.030 · DOI
- Tsalkova, 2012, Isoform-specific antagonists of exchange proteins directly activated by cAMP, Proc. Natl. Acad. Sci. U.S.A., 109, 18613, 10.1073/pnas.1210209109 · DOI
- Zhu, 2015, Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 “therapeutic window”, Sci. Rep., 5, 10.1038/srep09344 · DOI
- Brown, 2014, Identification and validation of modulators of exchange protein activated by cAMP (Epac) activity: structure-function implications for Epac activation and inhibition, J. Biol. Chem., 289, 8217, 10.1074/jbc.M114.548636 · DOI
- Brown, 2014, Allosteric inhibition of Epac: computational modeling and experimental validation to identify allosteric sites and inhibitors, J. Biol. Chem., 289, 29148, 10.1074/jbc.M114.569319 · doi:10.1074/jbc.m114.569319
- Laudette, 2019, Identification of a pharmacological inhibitor of Epac1 that protects the heart against acute and chronic models of cardiac stress, Cardiovasc. Res., 115, 1766, 10.1093/cvr/cvz076 · DOI
- Courilleau, 2012, Identification of a tetrahydroquinoline analog as a pharmacological inhibitor of the cAMP-binding protein Epac, J. Biol. Chem., 287, 44192, 10.1074/jbc.M112.422956 · DOI
- Courilleau, 2013, The R-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1), Biochem. Biophys. Res. Commun., 440, 443, 10.1016/j.bbrc.2013.09.107 · DOI
- Sonawane, 2017, Structure-activity relationship studies with tetrahydroquinoline analogs as EPAC inhibitors, ACS Med. Chem. Lett., 8, 1183, 10.1021/acsmedchemlett.7b00358 · doi:10.1021/acsmedchemlett.7b00358
- Boulton, 2018, Mechanism of selective enzyme inhibition through uncompetitive regulation of an allosteric agonist, J. Am. Chem. Soc., 140, 9624, 10.1021/jacs.8b05044 · doi:10.1021/jacs.8b05044
- Ahmed, 2019, Recent advances in EPAC-targeted therapies: a biophysical perspective, Cells, 8, 1462, 10.3390/cells8111462 · doi:10.3390/cells8111462
- Parnell, 2017, Identification of a novel, small molecule partial agonist for the cyclic AMP sensor, EPAC1, Sci. Rep., 7, 10.1038/s41598-017-00455-7 · DOI
- Schwede, 2000, Cyclic nucleotide analogs as biochemical tools and prospective drugs, Pharmacol. Ther., 87, 199, 10.1016/S0163-7258(00)00051-6 · DOI · Paper page
- Enserink, 2002, A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK, Nat. Cell Biol., 4, 901, 10.1038/ncb874 · DOI · Paper page
- Christensen, 2003, cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension, J. Biol. Chem., 278, 35394, 10.1074/jbc.M302179200 · DOI · Paper page
- Rehmann, 2003, Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac, J. Biol. Chem., 278, 38548, 10.1074/jbc.M306292200 · DOI
- Poppe, 2008, Cyclic nucleotide analogs as probes of signaling pathways, Nat. Methods, 5, 277, 10.1038/nmeth0408-277 · DOI · Paper page
- Vliem, 2008, 8-pCPT-2′-O-Me-cAMP-AM: an improved Epac-selective cAMP analogue, ChemBioChem, 9, 2052, 10.1002/cbic.200800216 · DOI
- Dodge-Kafka, 2005, The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways, Nature, 437, 574, 10.1038/nature03966 · DOI · Paper page
- Conti, 2007, Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling, Annu. Rev. Biochem., 76, 481, 10.1146/annurev.biochem.76.060305.150444 · DOI · Paper page
- Wiejak, 2019, The novel exchange protein activated by cyclic AMP 1 (EPAC1) agonist, I942, regulates inflammatory gene expression in human umbilical vascular endothelial cells (HUVECs), Biochim. Biophys. Acta Mol. Cell Res., 1866, 264, 10.1016/j.bbamcr.2018.11.004 · DOI
- Barker, 2017, The potential of a novel class of EPAC-selective agonists to combat cardiovascular Inflammation, J. Cardiovasc. Dev. Dis., 4, 22, 10.3390/jcdd4040022 · DOI
- Tsalkova, 2012, A fluorescence-based high-throughput assay for the discovery of exchange protein directly activated by cyclic AMP (EPAC) antagonists, PLoS ONE, 7, 10.1371/journal.pone.0030441 · DOI
- Boulton, 2019, Mechanisms of specific versus nonspecific interactions of aggregation-prone inhibitors and attenuators, J. Med. Chem., 62, 5063, 10.1021/acs.jmedchem.9b00258 · DOI
- Selvaratnam, 2011, Mapping allostery through the covariance analysis of NMR chemical shifts, Proc. Natl. Acad. Sci. U.S.A., 108, 6133, 10.1073/pnas.1017311108 · DOI · Paper page
- Eghbalnia, 2005, Protein energetic conformational analysis from NMR chemical shifts (PECAN) and its use in determining secondary structural elements, J. Biomol. NMR, 32, 71, 10.1007/s10858-005-5705-1 · DOI
- Zwahlen, 1997, Methods for measurement of intermolecular NOEs by multinuclear NMR spectroscopy: application to a bacteriophage λ N-peptide/ boxB RNA complex, J. Am. Chem. Soc., 119, 6711, 10.1021/ja970224q · DOI · Paper page
- Melacini, 2000, Separation of intra- and intermolecular NOEs through simultaneous editing and J -compensated filtering: A 4D quadrature-free constant-time J -resolved approach, J. Am. Chem. Soc., 122, 9735, 10.1021/ja0015996 · doi:10.1021/ja0015996
- Medek, 2000, The use of differential chemical shifts for determining the binding site location and orientation of protein-bound ligands, J. Am. Chem. Soc., 122, 1241, 10.1021/ja993921m · DOI
- Mayer, 2001, Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor, J. Am. Chem. Soc., 123, 6108, 10.1021/ja0100120 · DOI · Paper page
- Das, 2009, Dynamically driven ligand selectivity in cyclic nucleotide binding domains, J. Biol. Chem., 284, 23682, 10.1074/jbc.M109.011700 · DOI
- Delaglio, 1995, NMRPipe: a multidimensional spectral processing system based on UNIX pipes, J. Biomol. NMR, 6, 277, 10.1007/BF00197809 · DOI · Paper page
- Goddard, 2008, Sparky 3
- Yamazaki, 1995, NMR pulse schemes for the sequence-specific assignment of arginine guanidino 15N and 1H chemical shifts in proteins, J. Am. Chem. Soc., 117, 3556, 10.1021/ja00117a025 · doi:10.1021/ja00117a025
- Wang, 1995, An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule, FEBS Lett., 360, 111, 10.1016/0014-5793(95)00062-E · DOI · Paper page
- Byun, 2018, NMR methods to dissect the molecular mechanisms of disease-related mutations (DRMs): Understanding how DRMs remodel functional free energy landscapes, Methods, 148, 19, 10.1016/j.ymeth.2018.05.018 · DOI · Paper page
- de Hoon, 2004, Open source clustering software, Bioinformatics, 20, 1453, 10.1093/bioinformatics/bth078 · DOI · Paper page
- VanSchouwen, 2015, Mechanism of cAMP partial agonism in protein kinase G (PKG), J. Biol. Chem., 290, 28631, 10.1074/jbc.M115.685305 · DOI
- Boulton, 2016, Advances in NMR methods to map allosteric sites: from models to translation, Chem. Rev., 116, 6267, 10.1021/acs.chemrev.5b00718 · DOI · Paper page
Cited by
CHESPA/CHESCA-SPARKY: automated NMR data analysis plugins for SPARKY to map protein allostery
Shao, H., Boulton, S., Olivieri, C., Mohamed, H., Akimoto, M., Subrahmanian, M. V., Veglia, G., Markley, J. L., Melacini, G., & Lee, W. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btaa781 · Cited by 18
Self-citationOlivieri, C., Walker, C., Veliparambil Subrahmanian, M., Porcelli, F., Taylor, S. S., Bernlohr, D. A., & Veglia, G. (2023) · FEBS Letters · doi:10.1002/1873-3468.14610 · Cited by 10
Metadata
- Authors
- Shao, H., Mohamed, H., Boulton, S., Huang, J., Wang, P., Chen, H., Zhou, J., Luchowska-Stańska, U., Jentsch, N. G., Armstrong, A. L., Magolan, J., Yarwood, S., & Melacini, G.
- Affiliations
- McMaster University , , , ,
- University of Texas Medical Branch , , , ,
- Heriot-Watt University , , Edinburgh Campus , ,
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-04-16
- Volume
- 63
- Issue
- 9
- Pages
- 4762-4775
- ISSN
- 0022-2623
- 1520-4804
- Cited by
- 21
- References
- 1
- Language
- en
- Licence
- Funders
- Canadian Institutes of Health Research (389522)
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2019-05990)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanism of Action of an EPAC1-Selective Competitive Partial Agonist. https://app.cochat.ai/papers/10.1021/acs.jmedchem.9b02151
- The paper
- Shao, H., Mohamed, H., Boulton, S., Huang, J., Wang, P., Chen, H., Zhou, J., Luchowska-Stańska, U., Jentsch, N. G., Armstrong, A. L., Magolan, J., Yarwood, S., & Melacini, G. (2020). Mechanism of Action of an EPAC1-Selective Competitive Partial Agonist. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.9b02151
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.